Elliptic Laboratories ASA
OSE:ELABS.OL
17.56 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 74.198 | 115.582 | 176.437 | 216.827 | 98.569 | 32.745 | 14.071 | 34.833 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 74.198 | 115.582 | 176.437 | 216.827 | 98.569 | 32.745 | 14.071 | 34.833 |
| Net Receivables
| 0 | 60.612 | 47.339 | 29.025 | 18.227 | 14.31 | 14.77 | 3.124 |
| Inventory
| 0 | 0 | 1.782 | 1.324 | 4.805 | 3.129 | 0 | 0 |
| Other Current Assets
| 121.253 | 9.448 | 5.714 | 17.773 | 3.65 | 7.117 | 5.914 | 7.001 |
| Total Current Assets
| 195.451 | 185.642 | 225.619 | 264.949 | 121.601 | 57.3 | 37.308 | 47.465 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 16.658 | 19.907 | 2.256 | 2.79 | 5.023 | 7.255 | -2.133 | -1.059 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 66.252 | 57.814 | 47.574 | 36.564 | 28.241 | 16.552 | 9.848 | 3.225 |
| Goodwill and Intangible Assets
| 66.252 | 57.814 | 47.574 | 36.564 | 28.241 | 16.552 | 9.848 | 3.225 |
| Long Term Investments
| 0 | 0 | 5.038 | 4.517 | 4.05 | 2.092 | 2.133 | 1.059 |
| Tax Assets
| 75.42 | 77.685 | 68.837 | 62.534 | 59.807 | 56.169 | 52.952 | 46.701 |
| Other Non-Current Assets
| 7.245 | 8.861 | -0.001 | 0.001 | 0 | 0 | 2.133 | 1.059 |
| Total Non-Current Assets
| 165.575 | 164.267 | 123.704 | 106.406 | 97.121 | 82.068 | 64.933 | 50.984 |
| Total Assets
| 361.026 | 349.909 | 349.324 | 371.356 | 218.722 | 139.368 | 102.241 | 98.448 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 1.301 | 3.855 | 1.668 | 3.029 | 0.989 | 0.835 | 2.527 | 1.1 |
| Short Term Debt
| 8.625 | 7.99 | 6.184 | 6.611 | 6.203 | 31.481 | 33.661 | -1.159 |
| Tax Payables
| 0 | 4.76 | 3.104 | 2.309 | 2.282 | 2.832 | 3.045 | 2.139 |
| Deferred Revenue
| 0 | 0 | 0 | 8.415 | 0 | 7.807 | 8.266 | 7.436 |
| Other Current Liabilities
| 15.032 | 8.321 | 6.223 | -10.723 | 4.142 | 4.983 | -2.002 | -2.084 |
| Total Current Liabilities
| 24.958 | 24.926 | 17.179 | 18.056 | 13.616 | 40.13 | 54.843 | 12.59 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 10.727 | 17.874 | 6.523 | 10.53 | 17.002 | 19.205 | 0 | 14 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | -0.715 | 0 | 0 | -0.747 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0.715 | 0.715 | 0.715 | 0.747 |
| Other Non-Current Liabilities
| -0.001 | 0.001 | 0.001 | 0.001 | -0 | 0 | -0.715 | 0 |
| Total Non-Current Liabilities
| 10.726 | 17.875 | 6.524 | 10.531 | 17.002 | 19.205 | 45.535 | 14 |
| Total Liabilities
| 35.684 | 42.801 | 23.703 | 28.587 | 30.618 | 59.335 | 54.843 | 26.59 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 1.053 | 1.048 | 1.041 | 1.038 | 0.958 | 0.875 | 0.856 | 0.856 |
| Retained Earnings
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -48.942 | -20.934 | -0.814 | 12.503 | 70.072 | 40.327 | 68.506 |
| Other Total Stockholders Equity
| 324.289 | 355.002 | 345.514 | 342.545 | 187.153 | 70.644 | 6.214 | 2.496 |
| Total Shareholders Equity
| 325.342 | 307.108 | 325.621 | 342.769 | 188.104 | 80.033 | 47.398 | 71.858 |
| Total Equity
| 325.342 | 307.108 | 325.621 | 342.769 | 188.104 | 80.033 | 47.398 | 71.858 |
| Total Liabilities & Shareholders Equity
| 361.026 | 349.909 | 349.324 | 371.356 | 218.722 | 139.368 | 102.241 | 98.448 |